No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
490 |
4. Check minimum number of eventsNone |
490 |
5. Include endpointsNone |
490 |
6. Filter based on genotype QC (FinnGen only) |
490 |
Control definitions (FinnGen only)
- Control exclude
- D3_COAGDEF_PURPUR_HAEMORRHAGIC
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D68
- Name in latin
- Morbus von Willebrand
Similar endpoints
↥List of similar endpoints to
Von Willebrand disease
based on the number of shared cases.
Similar with more cases:
- Other coagulation defects
- Coagulation defects, purpura and other haemorrhagic conditions
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3361 | 2297 | 1052 |
| Only index persons | 3158 | 2208 | 950 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.07 | 0.03 |
| Only index persons | 0.07 | 0.08 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 28.87 | 33.42 | 18.84 |
| Only index persons | 28.84 | 33.23 | 18.62 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 490 | 413 | 77 |
| Unadjusted period prevalence (%) | 0.12 | 0.14 | 0.03 |
| Median age at first event (years) | 37.08 | 36.97 | 37.73 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 441
- Matched controls
- 4410
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D68.0
ICD-10 Finland
Von Willebrand disease
+∞
323.0
428
*
B02AA02
ATC
tranexamic acid; systemic
21.5
172.7
325
508
126
Kela drug reimbursment
Chronic coagulation defects
+∞
132.0
120
*
D68.9
ICD-10 Finland
Coagulation defect, unspecified
+∞
53.2
50
*
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
102.4
42.7
46
5
D68.8
ICD-10 Finland
Other specified coagulation defects
154.2
40.5
42
*
2864A
ICD-9 Finland
Coagulation defects, von Willebrand's disease
+∞
34.8
33
*
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
363.5
34.4
34
*
28630
ICD-8 Finland
Coagulation defects, Vascular haemophilia
+∞
25.2
24
*
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
13.6
23.1
40
32
N02AX02
ATC
tramadol; systemic, rectal
2.7
20.7
214
1150
EBA10
NOMESCO Finland
Surgical removal of tooth
3.5
20.3
109
380
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
6.3
20.0
55
98
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
3.6
19.0
96
318
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.5
18.9
236
1388
D68.2
ICD-10 Finland
Hereditary deficiency of other clotting factors
+∞
16.8
16
*
N02BE01
ATC
paracetamol; systemic, rectal
3.3
16.5
397
3219
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
5.0
16.5
55
123
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
34.8
15.9
20
6
R04.0
ICD-10 Finland
Epistaxis
5.9
15.3
43
79
M01AE01
ATC
ibuprofen; systemic, rectal
0.4
14.2
297
3677
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
12.9
197
1202
2BD06
NOMESCO Finland
NA
+∞
12.6
12
*
N02AJ06
ATC
codeine and paracetamol; systemic
2.1
12.0
186
1130
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.1
11.5
165
967
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
10.7
171
1042
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
2.9
10.6
69
268
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
10.6
172
1051
ZXE00
NOMESCO Finland
One hour or less
2.0
10.6
198
1279
D66
ICD-10 Finland
Hereditary factor VIII deficiency
112.5
10.5
11
*
194
Kela drug reimbursment
Blood coagulation factor VIII and von Willebrand factor for the treatment of von Willebrand disease
+∞
10.5
10
*
D69.1
ICD-10 Finland
Qualitative platelet defects
+∞
10.5
10
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.7
10.4
46
135
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
10.1
131
728
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.0
9.8
59
217
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
56.2
9.7
11
*
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
30.7
9.4
12
*
J01DB01
ATC
cefalexin; oral
2.2
9.4
374
3150
R51.80
ICD-10 Finland
Headache
2.3
9.3
94
462
Z71.8
ICD-10 Finland
Other specified counselling
2.1
9.1
130
746
SAA03
NOMESCO Finland
Extended examination of mouth
1.9
9.0
203
1379
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.1
8.8
117
650
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
8.6
139
833
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.2
8.5
44
147
UJF32
NOMESCO Finland
Coloscopy
2.1
8.5
112
619
B02BD06
ATC
von Willebrand factor and coagulation factor VIII in combination; parenteral, topical, urethral
+∞
8.4
8
*
B02BD02
ATC
coagulation factor VIII; parenteral, topical, urethral
+∞
8.4
8
*
D69.0
ICD-10 Finland
Allergic purpura
+∞
8.4
8
*
R42
ICD-10 Finland
Dizziness and giddiness
2.2
8.3
96
501
J01FA10
ATC
azithromycin; systemic
1.8
8.3
290
2259
G43.9
ICD-10 Finland
Migraine, unspecified
2.9
8.2
49
181
ZX120
NOMESCO Finland
Intravenous
2.8
8.1
54
211
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
8.1
162
1047
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.0
8.1
130
776
H02AB06
ATC
prednisolone; systemic
1.8
7.9
207
1460
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
5.2
7.8
23
46
R01AD12
ATC
fluticasone furoate; nasal
1.8
7.6
163
1074
C01CA24
ATC
epinephrine; parenteral
2.9
7.6
47
175
AA1AD
NOMESCO Finland
CT of head and brain
2.1
7.5
90
476
R03AC02
ATC
salbutamol; inhalant
1.7
7.4
248
1871
N03AX16
ATC
pregabalin; oral
2.0
7.4
108
620
N03AX12
ATC
gabapentin; oral
2.3
7.4
74
362
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.3
7.4
67
313
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
2.8
7.4
47
181
M25.5
ICD-10 Finland
Pain in joint
1.8
7.3
141
893
9981A
ICD-9 Finland
Other complications of procedures, not elsewhere classified, Haemorrhage or haematoma complicating a procedure
16.0
7.3
11
7
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
7.2
174
1185
Z00.0
ICD-10 Finland
General medical examination
2.0
7.0
91
499
R07.4
ICD-10 Finland
Chest pain, unspecified
2.0
7.0
101
574
J01FF01
ATC
clindamycin; systemic
1.9
6.9
120
734
S06.0
ICD-10 Finland
Concussion
2.5
6.8
54
236
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
6.8
103
597
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
2.6
6.7
49
203
Z35.9
ICD-10 Finland
Supervision of high-risk pregnancy, unspecified
3.5
6.7
29
86
Z31.5
ICD-10 Finland
Genetic counselling
2.9
6.6
39
144
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
6.5
237
1806
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.0
6.5
93
529
G47.3
ICD-10 Finland
Sleep apnoea
2.0
6.4
85
468
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
6.4
63
305
P01AB01
ATC
metronidazole; oral, rectal
1.7
6.4
195
1411
J01MA02
ATC
ciprofloxacin; systemic
1.7
6.3
148
992
2BDXX
NOMESCO Finland
NA
+∞
6.3
6
*
O991, D680
ICD-10 Finland
NA
+∞
6.3
6
*
D68.1
ICD-10 Finland
Hereditary factor XI deficiency
+∞
6.3
6
*
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
6.3
84
466
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.7
6.2
252
1966
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
6.2
192
1391
J01DA01
ATC
[U] cefalexin; systemic
1.7
6.2
280
2253
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
6.2
78
423
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
6.1
65
326
SPAT1263
SPAT
Sampling
1.7
6.1
185
1333
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.1
6.0
69
358
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
6.0
227
1733
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
189
7
437.57
201.53
5.6
1.3
%
83.3
152.7
—
177
7
(3036489) Thrombin time
153
135
16.02
155.31
3.9
2.6
s
21.1
20.9
0.08
126
116
(3018677) aPTT in Platelet poor plasma by Coagulation assay
258
475
10.36
152.65
3.6
1.9
s
30.9
29.2
4.51
248
458
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
63
14
51.49
108.08
1.3
1.0
%
116.6
138.9
0.94
56
14
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
59
14
47.77
99.57
1.2
1.0
%
94.6
96.4
—
26
8
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
110
114
12.15
98.66
4.3
2.9
%
98.0
97.4
0.09
110
104
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
57
14
45.94
95.34
1.2
1.0
%
100.7
104.5
—
26
8
(3033658) Prothrombin time (PT) actual/Normal
243
936
4.17
53.52
5.7
3.3
%
100.2
96.3
1.58
233
906
(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay
45
0
+∞
47.69
1.5
0.0
%
51.2
—
—
39
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
108
287
4.54
38.00
2.7
2.3
ml/min/173m2
85.3
75.0
1.85
84
101
(3004789) Transferrin [Mass/volume] in Serum or Plasma
138
470
3.70
34.13
4.2
2.1
g/l
2.5
2.5
0.03
133
429
(3022948) Iron [Moles/volume] in Serum or Plasma
144
523
3.48
32.05
4.2
2.1
umol/l
14.7
14.0
0.56
139
475
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
204
926
3.06
31.05
3.2
1.8
mg/l
0.6
0.8
1.97
154
698
(3024561) Albumin [Mass/volume] in Serum or Plasma
269
1469
2.84
28.39
5.0
4.1
g/l
37.3
36.5
1.56
252
1375
(3027945) Reticulocytes/100 erythrocytes in Blood
96
302
3.71
26.21
3.6
2.8
%
1.7
1.7
0.05
88
267
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
148
622
2.98
25.03
3.5
2.5
mmol/l
2.4
2.4
0.49
141
543
(3032080) INR in Blood by Coagulation assay
234
1252
2.66
24.76
6.7
5.8
inr
1.1
1.1
0.09
92
411
(3015377) Calcium [Moles/volume] in Serum or Plasma
234
1285
2.57
23.03
3.4
3.0
mmol/l
2.4
2.4
0.41
220
1144
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
186
950
2.54
20.90
4.0
2.0
mg/l
2.9
3.0
0.20
166
810
(3001604) Monocytes [#/volume] in Blood
305
2015
2.36
18.47
6.6
5.6
e9/l
0.5
0.5
0.34
282
1766
(3006315) Basophils [#/volume] in Blood
306
2026
2.36
18.42
6.6
5.6
e9/l
0.0
0.0
1.46
282
1771
(3013115) Eosinophils [#/volume] in Blood
313
2102
2.35
18.08
6.7
5.9
e9/l
0.2
0.2
0.31
288
1865
(3019198) Lymphocytes [#/volume] in Blood
311
2085
2.35
18.01
6.6
5.6
e9/l
2.0
2.0
0.03
287
1860
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
394
2982
2.64
16.65
7.6
6.6
u/l
75.2
76.9
0.40
378
2805
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
285
1913
2.17
15.49
5.2
5.5
umol/l
10.5
9.8
0.22
268
1807
(3013650) Neutrophils [#/volume] in Blood by Automated count
329
2353
2.21
14.99
9.1
8.7
e9/l
3.9
3.9
0.01
302
2056
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
264
1737
2.13
14.91
6.4
5.8
mmol/l
1.2
1.2
0.26
227
1467
(3006504) Eosinophils/100 leukocytes in Blood
280
1900
2.11
14.38
6.9
5.6
%
2.6
2.8
1.15
268
1772
(42870588) Differential panel, method unspecified - Blood
209
1274
2.12
14.27
6.0
5.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
272
1833
2.09
14.15
6.9
5.7
%
0.7
0.7
0.01
260
1710
(3019069) Monocytes/100 leukocytes in Blood
280
1910
2.09
14.06
7.2
5.9
%
7.8
8.1
1.14
269
1795
(3013707) Erythrocyte sedimentation rate by Westergren method
387
3010
2.36
13.61
4.6
3.9
mm/h
9.3
10.3
0.85
370
2790
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
239
1551
2.06
13.61
5.4
5.2
mmol/l
1.2
1.2
0.02
223
1414
(3021589) Normoblasts [#/volume] in Blood
271
1847
2.05
13.40
11.4
8.2
e9/l
0.0
0.0
1.05
234
1503
(40758558) Short blood count panel - Blood
174
1009
2.12
13.36
5.9
6.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
282
1966
2.02
12.91
7.0
5.7
%
29.1
29.3
0.11
271
1850
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
12
0
+∞
12.55
1.4
0.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
177
1057
2.06
12.39
4.3
3.6
ph
7.4
7.4
0.04
35
194
(3018010) Neutrophils/100 leukocytes in Blood
278
1952
1.98
12.20
6.6
5.5
%
56.9
56.5
0.20
267
1838
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
200
1273
1.96
11.51
2.8
2.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
289
2084
1.94
11.42
4.7
2.8
ug/l
91.5
74.6
0.98
274
1943
(3000850) Epithelial cells [#/volume] in Urine
134
746
2.10
11.16
2.2
2.3
e6/l
7.5
8.0
0.12
119
654
(3018095) Leukocytes [#/volume] in Urine
206
1337
1.93
11.09
3.0
3.3
e6/l
33.6
60.8
1.16
151
886
(3013826) Glucose [Moles/volume] in Serum or Plasma
291
2130
1.90
10.70
4.3
3.9
mmol/l
6.3
6.5
1.11
274
1940
(3023520) Reticulocytes [#/volume] in Blood
54
209
2.78
10.12
3.6
2.6
e9/l
80.3
70.6
1.02
35
155
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
466
4122
3.66
9.94
15.8
11.0
mg/l
19.8
20.2
0.10
408
3142
(3002582) Erythrocytes [#/volume] in Urine
173
1092
1.90
9.89
2.7
2.8
e6/l
27.8
115.9
0.78
137
808
(3030467) Casts [#/volume] in Urine by Automated count
157
972
1.91
9.45
2.6
2.7
e6/l
0.3
0.4
0.13
125
700
(36304419) Bacteria [Presence] in Urine
154
973
1.85
8.56
2.6
2.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
399
3368
1.99
8.15
5.5
4.1
pmol/l
14.5
14.5
0.31
384
3126
(3026782) Osmolality of Urine
116
700
1.86
7.33
2.0
2.3
mosm/kgh2o
525.8
539.3
0.22
99
586
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
249
1894
1.64
6.69
5.7
3.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
153
1029
1.71
6.60
4.8
4.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
53
250
2.26
6.55
1.1
1.1
titre
—
106.0
—
0
5
(3048689) Calprotectin [Mass/mass] in Stool
97
580
1.84
6.24
2.0
2.2
ug/g
71.7
105.8
1.11
71
441
(3037467) Urinalysis macro (dipstick) panel - Urine
335
2792
1.63
5.85
4.8
3.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
57
292
2.08
5.73
4.7
4.5
%
0.5
0.3
0.19
15
57
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
162
1142
1.63
5.70
2.4
2.3
u/l
54.0
57.4
0.77
151
1059
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
85
502
1.84
5.66
2.2
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
190
1402
1.58
5.48
1.9
1.8
pmol/l
103.5
97.7
0.69
97
721
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
172
1244
1.59
5.38
2.9
3.0
ng/l
22.2
62.3
0.60
87
693
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
226
1741
1.55
5.36
2.8
2.3
nmol/l
75.3
76.1
0.16
215
1587
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
113
738
1.69
5.30
2.5
2.9
ng/l
1304.2
794.6
0.61
93
619
(3005322) IgE [Units/volume] in Serum or Plasma
58
309
1.99
5.25
1.4
1.2
u/ml
78.4
224.5
1.18
53
288
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
65
3.17
5.12
3.4
3.3
u/ml
0.2
0.4
3.18
15
33
(3044640) Blood type and Crossmatch panel - Blood
168
1221
1.57
5.10
3.6
2.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
55
294
1.98
4.93
3.9
4.3
%
0.9
0.7
0.20
14
52
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
55
294
1.98
4.93
3.3
3.7
pmol/l
4.5
4.7
0.87
48
261
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
55
294
1.98
4.93
5.7
7.4
kpa
5.3
5.2
0.33
55
282
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
468
4367
2.60
4.88
12.4
9.0
u/l
25.2
25.0
0.08
463
4240
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
433
3928
1.88
4.86
6.3
4.8
mu/l
1.8
2.1
0.43
416
3679
(3035350) Ketones [Presence] in Urine by Test strip
251
2007
1.51
4.85
4.3
3.3
estimate
0.0
0.0
0.00
61
401
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
149
1065
1.57
4.82
1.8
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
149
1070
1.56
4.70
4.8
3.5
estimate
0.0
0.0
0.50
65
407
(3037522) Nuclear Ab [Titer] in Serum
95
611
1.69
4.69
1.4
1.3
titre
798.1
487.0
0.46
21
126
(3017181) Myelocytes/100 leukocytes in Blood
58
323
1.90
4.62
4.8
4.3
%
1.4
0.8
0.68
18
82
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
421
3803
1.76
4.57
14.4
9.9
ml/min/173m2
89.9
88.4
0.73
377
3067
(3023368) Bacteria identified in Blood by Culture
117
800
1.61
4.53
4.1
3.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
55
303
1.92
4.53
4.7
4.5
%
0.2
0.1
0.20
15
71
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
152
1105
1.54
4.52
1.4
1.3
u/ml
0.6
1.5
1.38
54
309
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
60
342
1.86
4.46
2.0
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
465
4353
2.34
4.34
17.0
10.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
43
221
2.04
4.31
1.6
1.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
19
67
2.91
4.27
1.9
2.6
mmol/l
2.2
2.7
0.25
11
41
(3031040) Bacteria [#/volume] in Urine by Automated count
312
2651
1.49
4.22
5.2
4.0
e6/l
224.9
1439.0
—
7
43
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
177
1349
1.49
4.15
2.8
2.9
u/l
27.0
29.2
0.71
170
1290
(3003396) Base excess in Arterial blood by calculation
52
293
1.87
4.01
5.8
7.5
mmol/l
0.9
1.4
0.35
41
237
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
201
1581
1.46
3.98
4.5
3.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
50
279
1.88
3.98
3.9
3.5
mmol/l
1.2
1.2
0.03
45
236
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
127
911
1.53
3.95
2.9
2.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
33
159
2.15
3.92
5.8
4.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
112
788
1.55
3.79
1.3
1.3
u/ml
38.4
14.1
0.29
44
321
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
57
337
1.78
3.78
1.9
1.7
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
12
6.76
3.68
2.8
2.5
ug/l
60.8
90.2
—
8
12
(3009261) Glucose [Presence] in Urine by Test strip
248
2050
1.42
3.66
4.3
3.3
estimate
0.0
0.0
0.80
65
392
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
67
419
1.69
3.65
2.4
2.7
umol/l
9.6
7.3
0.17
57
357
(3022806) Fractional oxyhemoglobin in Capillary blood
12
35
3.49
3.64
1.7
1.9
%
90.6
91.6
0.24
12
35
(3021601) Nitrite [Presence] in Urine by Test strip
245
2026
1.42
3.58
5.6
4.5
estimate
0.0
0.0
0.50
64
404
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
364
3236
1.49
3.57
3.7
3.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
47
270
1.82
3.43
3.3
3.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
122
894
1.49
3.38
3.0
2.5
umol/l
318.8
5602.4
3.64
108
788
(3035320) C reactive protein [Mass/volume] in Body fluid
10
27
3.76
3.37
2.0
1.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
19
4.80
3.25
1.0
1.1
miu/ml
1845.9
1744.4
—
9
19
(3007853) Bacteria identified in Skin by Aerobe culture
65
418
1.64
3.20
2.1
1.6
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
11
6.44
3.19
1.1
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
19
79
2.46
3.17
1.1
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
324
2847
1.41
3.16
3.0
2.9
u/l
39.0
39.0
0.00
302
2708
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
111
809
1.48
3.14
1.4
1.3
iu/ml
27.4
30.4
0.08
33
268
(3052851) Hemolysis interference index of Serum or Plasma
21
92
2.34
3.14
2.7
2.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
88
612
1.53
3.11
3.3
3.1
ng/l
495.8
256.3
0.27
48
384
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
19
80
2.43
3.10
1.5
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
119
882
1.46
3.09
4.9
3.4
kg/l
1.0
1.0
0.69
18
117
(3009214) Lutropin [Units/volume] in Serum or Plasma
29
147
2.03
3.06
1.7
1.3
u/l
13.5
11.5
0.16
22
118
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
10
29
3.50
3.06
2.0
1.3
pg
33.4
32.3
—
10
29
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
34
183
1.92
3.05
1.5
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
75
2.45
3.00
1.5
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
15
57
2.68
2.99
1.5
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
12
40
3.05
2.99
2.3
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
150
1167
1.41
2.99
2.9
2.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
71
476
1.57
2.95
2.4
2.0
—
—
—
0
0
(3044889) 12 lead EKG panel
301
2629
1.38
2.93
3.4
3.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
136
1044
1.42
2.91
1.6
1.6
mmol/l
1.6
1.3
1.79
118
907
(3034426) Prothrombin time (PT)
7
13
5.45
2.88
1.0
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
57
365
1.64
2.86
3.6
3.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
18
77
2.39
2.85
4.6
3.9
%
57.4
57.2
0.02
18
77
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
80
557
1.52
2.82
2.5
2.4
e6/l
0.6
1.1
2.05
47
292
(3011397) Hemoglobin [Presence] in Urine by Test strip
116
872
1.43
2.78
4.5
3.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
12
42
2.90
2.77
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
9
24
3.80
2.68
1.2
3.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
20
94
2.18
2.58
1.5
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
151
1205
1.37
2.53
3.3
2.9
—
—
—
0
0
(44790048)
11
39
2.86
2.49
1.7
1.7
—
—
—
0
0
(44790047)
11
39
2.86
2.49
1.7
1.7
—
—
—
0
0
(44806118)
11
39
2.86
2.49
1.7
1.7
—
—
—
0
0
(44790049)
11
39
2.86
2.49
1.7
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
57
2.50
2.47
1.6
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
17
76
2.28
2.47
3.8
3.5
e9/l
4.6
4.4
0.10
17
76
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
53
348
1.59
2.42
3.3
2.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
28
154
1.87
2.39
1.9
1.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
16
71
2.30
2.36
2.3
2.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
59
2.41
2.31
1.6
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
46
296
1.61
2.29
2.3
2.3
u/l
4450.5
4019.1
0.04
15
133
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
47
2.59
2.28
1.7
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
23
3.52
2.28
1.1
1.0
—
—
—
0
0
(3035941) MCH [Entitic mass]
480
4659
2.48
2.25
26.7
16.5
pg
30.0
30.1
0.45
480
4606
(3024731) MCV [Entitic volume]
480
4659
2.48
2.25
26.7
16.6
fl
90.2
90.3
0.18
480
4607
(3026361) Erythrocytes [#/volume] in Blood
480
4660
2.47
2.23
26.8
16.6
e12/l
4.5
4.5
0.02
480
4555
(40768443) Skin Pathology biopsy report
28
158
1.82
2.22
1.1
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
10
36
2.81
2.21
1.4
1.1
u/ml
0.5
0.1
—
5
8
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
42
267
1.63
2.20
3.3
3.5
ng/l
80.7
69.8
0.37
37
241
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
74
534
1.45
2.20
2.5
2.5
e6/l
2.2
3.6
1.53
41
268
(3002256) Pathology report gross observation
72
517
1.46
2.19
1.2
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
480
4662
2.45
2.19
27.0
16.7
g/l
133.8
134.1
0.17
480
4610
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
25
137
1.87
2.17
1.7
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
14
4.32
2.15
2.0
7.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
51
342
1.55
2.15
2.1
2.4
u/l
30.0
32.3
0.28
45
295
(40768797) Stomach Pathology biopsy report
73
528
1.45
2.14
1.2
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
25
138
1.86
2.13
1.5
1.1
—
—
—
0
0
(4062490)
10
37
2.74
2.11
1.7
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
36
223
1.66
2.09
1.8
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
58
403
1.50
2.08
2.3
1.7
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
10
5.04
2.07
1.4
2.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
50
2.44
2.04
1.6
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
24
133
1.85
2.03
3.0
1.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
11
44
2.53
2.02
1.2
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
18
91
2.02
1.97
2.7
6.2
mmol/l
1.2
1.2
0.18
18
83
(3051651) Icteric interference index of Serum or Plasma
6
16
3.78
1.94
3.8
2.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
16
78
2.09
1.93
9.2
4.1
mmol/l
3.8
3.8
0.03
16
70
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
28
2.89
1.87
1.9
1.6
—
—
—
0
0
(3015736) pH of Urine
186
1587
1.28
1.85
4.1
3.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
17
3.56
1.84
1.0
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
423
4008
1.41
1.83
4.3
3.9
mmol/l
4.7
4.8
0.35
397
3769
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
35
2.60
1.81
1.8
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
69
513
1.40
1.76
2.4
1.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
119
964
1.31
1.75
1.6
1.5
g/l
1.9
2.2
1.51
79
601
(3009508) Creatinine [Moles/volume] in Urine
129
1059
1.30
1.72
2.9
3.0
mmol/l
7.3
7.6
0.36
109
922
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
75
2.03
1.71
1.3
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
33
212
1.60
1.70
2.4
2.2
ug/l
4.3
5.6
0.30
28
188
(3021788) Differential panel - Synovial fluid
12
55
2.21
1.68
1.2
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
31
197
1.61
1.67
2.4
2.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
55
397
1.43
1.66
1.3
1.2
iu/ml
162.4
155.2
0.04
21
167
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
69
2.06
1.66
1.3
1.2
u/ml
6.7
3.6
—
6
26
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
22
128
1.75
1.63
2.9
1.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
14
3.60
1.62
1.8
4.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
43
2.35
1.61
1.8
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
63
2.09
1.61
1.2
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
32
2.52
1.60
1.1
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
26
160
1.66
1.59
1.5
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
26
2.72
1.58
1.9
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.72
1.58
1.9
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.72
1.58
1.9
1.6
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
20
3.02
1.58
2.3
1.4
ug/l
14.2
25.8
—
6
20
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
25
153
1.67
1.56
1.3
1.9
—
—
—
0
0
(1616796) Gas panel - Central venous blood
13
64
2.06
1.55
2.0
2.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
13
64
2.06
1.55
1.1
1.3
—
25.3
—
0
6
(40768804) Tissue Pathology biopsy report
194
1692
1.24
1.54
2.2
2.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
26
162
1.64
1.52
1.5
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
15
3.36
1.52
1.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
21
2.88
1.51
1.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
21
2.88
1.51
2.7
3.1
—
—
—
0
0
(3020891) Body temperature
18
101
1.81
1.51
5.6
4.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
103
837
1.29
1.48
2.2
2.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
16
87
1.87
1.47
1.2
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
52
2.14
1.45
1.6
1.7
—
—
—
0
0
(3019225) pH of Specimen
45
322
1.44
1.44
4.5
3.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
23
141
1.66
1.44
1.8
2.0
iu/l
2.0
6.0
2.76
11
50
(3044242) Glucose [Moles/volume] in Arterial blood
5
16
3.15
1.44
1.6
6.9
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
16
3.15
1.44
1.0
1.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
24
149
1.64
1.44
1.5
1.4
g/l
1.1
1.2
1.65
24
144
(3045414) Leukocytes [Presence] in Urine
26
165
1.61
1.43
2.1
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
26
165
1.61
1.43
2.6
2.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
424
4053
1.34
1.43
4.6
4.2
mmol/l
2.8
2.9
0.40
398
3787
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
23
142
1.65
1.41
1.4
1.5
g/l
0.2
0.2
1.58
23
137
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
418
3990
1.32
1.40
4.2
3.8
mmol/l
1.5
1.5
2.05
391
3736
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
94
762
1.29
1.38
2.2
2.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
23
2.63
1.37
4.3
2.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
14
75
1.89
1.35
1.7
4.7
—
3.1
—
0
8
(4268621)
9
42
2.16
1.34
2.0
2.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
25
161
1.58
1.31
1.2
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
39
536
0.70
1.30
1.2
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
48
2.11
1.28
1.3
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
405
3862
1.28
1.28
4.3
3.8
mmol/l
5.7
5.7
0.19
370
3570
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
54
409
1.36
1.27
6.1
5.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
36
254
1.45
1.26
1.3
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
8
36
2.24
1.24
1.1
1.1
—
6.6
—
0
9
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
36
2.24
1.24
4.1
1.6
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
10
49
2.06
1.22
1.6
1.4
mu/l
27.0
60.9
—
10
44
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
78
1.82
1.22
1.9
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
38
273
1.42
1.22
3.0
2.9
e9/l
4.7
4.1
0.44
27
233
(3022145) Colonoscopy Study observation
55
423
1.34
1.18
1.2
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
50
2.02
1.17
1.3
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
49
372
1.35
1.15
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
20
127
1.60
1.13
1.3
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
11
58
1.92
1.13
1.8
5.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
43
321
1.37
1.12
1.7
1.3
iu/l
21.5
27.0
0.61
38
271
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
51
1.98
1.12
1.3
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
32
2.20
1.08
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
32
2.20
1.08
1.3
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
59
1.88
1.08
1.3
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
68
547
1.28
1.08
1.9
1.7
nmol/l
1099.8
1183.8
0.35
54
408
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
376
3580
1.22
1.05
5.3
4.8
mmol/mol
38.0
38.6
0.54
345
3378
(42529406) Shigella sp [Presence] in Stool by Culture
20
130
1.56
1.04
1.3
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
75
1.75
1.03
1.3
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
34
2.07
1.03
1.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
47
1.93
1.02
1.2
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
400
3836
1.23
1.02
3.9
3.5
mmol/l
1.4
1.2
2.95
377
3581
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
48
1.89
1.01
1.3
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
35
2.01
1.00
1.0
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
35
2.01
1.00
1.7
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
35
2.01
1.00
1.1
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
33
241
1.40
0.99
2.6
2.5
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
9
49
1.85
0.99
2.9
3.0
u/ml
26.9
38.5
—
9
49
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
49
1.85
0.99
1.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
36
1.96
0.97
1.0
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
36
1.96
0.97
2.0
2.9
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
13
77
1.71
0.96
1.1
1.2
u/ml
140.0
236.8
—
8
49
(3026389) Candida sp identified in Specimen by Organism specific culture
9
51
1.78
0.95
1.9
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
32
235
1.39
0.94
6.0
7.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
37
1.90
0.94
4.3
1.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
27
2.24
0.93
1.0
2.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
12
70
1.73
0.93
1.4
1.3
u/ml
91.4
120.9
—
5
15
(3021879) Hepatitis B virus core Ab [Presence] in Serum
44
341
1.32
0.93
1.6
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
109
943
1.20
0.91
3.7
4.0
mg/mmol
8.0
9.8
0.23
67
578
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
127
1.52
0.90
1.3
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
30
2.01
0.87
1.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
12
72
1.68
0.86
1.2
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
80
1.64
0.85
1.1
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
57
1.77
0.84
1.3
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
113
1.52
0.83
2.3
2.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
11
65
1.71
0.83
1.7
1.4
—
—
—
0
0
(3013512) EKG study
109
952
1.19
0.82
3.3
3.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
34
259
1.34
0.82
1.5
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
34
259
1.34
0.82
1.5
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
71
595
1.23
0.82
1.5
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
54
439
1.26
0.81
1.6
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
47
1.71
0.81
2.1
2.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
26
190
1.39
0.81
1.8
3.2
mmol/l
1.6
1.3
0.15
18
139
(3021960) Folate [Moles/volume] in Serum or Plasma
95
822
1.19
0.80
1.6
1.5
nmol/l
22.8
21.7
0.28
85
705
(3023419) Bacteria identified in Sputum by Culture
6
33
1.83
0.79
3.2
2.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
34
261
1.33
0.79
1.5
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
82
1.60
0.78
1.1
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
36
279
1.31
0.78
1.4
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
102
890
1.18
0.78
3.0
3.2
mg/l
773.3
300.2
0.29
66
548
(4027681)
6
34
1.77
0.76
1.0
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
12
75
1.62
0.75
1.3
1.5
e6/l
3613.6
11534.6
—
5
52
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
55
1.65
0.74
2.7
2.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
144
1298
1.15
0.73
1.8
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
142
1.43
0.73
4.8
8.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.2
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
76
1.59
0.72
1.4
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
24
177
1.37
0.72
1.9
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
41
1.72
0.70
1.9
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
63
532
1.21
0.69
2.0
1.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
42
339
1.26
0.69
14.9
14.5
inr
1.1
1.2
—
5
56
(4281824)
7
42
1.68
0.68
1.1
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
27
1.86
0.68
1.2
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
33
259
1.29
0.67
1.5
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
24
180
1.35
0.66
1.4
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
10
62
1.63
0.65
1.8
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
29
1.73
0.64
1.2
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
29
1.73
0.64
1.0
1.6
g/l
0.9
0.9
—
5
29
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
13
87
1.51
0.64
1.5
1.1
—
12.1
—
0
5
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
49
1.64
0.62
1.0
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
64
548
1.19
0.62
1.5
1.6
%
1.5
1.4
0.49
55
497
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
72
1.54
0.59
1.4
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
53
1.52
0.58
1.5
1.2
nmol/l
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
54
1.49
0.57
1.1
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
36
293
1.25
0.57
1.1
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
14
98
1.44
0.57
2.7
2.3
g/l
1.1
0.7
0.22
14
90
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
38
1.59
0.54
1.2
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
38
1.59
0.54
1.3
1.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
13
91
1.44
0.53
2.3
2.1
g/l
40.4
38.7
0.73
13
84
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
6
39
1.54
0.53
1.0
1.0
g/l
1.4
1.4
—
6
34
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
66
1.53
0.53
1.0
1.4
—
—
—
0
0
(4010399)
31
251
1.25
0.52
1.5
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
64
1.41
0.51
1.2
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
122
1116
1.12
0.50
2.2
2.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
27
217
1.26
0.49
1.7
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
24
190
1.28
0.49
2.5
2.5
e6/l
0.1
0.2
0.43
24
183
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
17
128
1.34
0.48
1.4
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
27
218
1.25
0.47
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
68
1.48
0.47
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
68
1.48
0.47
1.3
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
26
210
1.25
0.46
1.6
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
13
95
1.38
0.44
1.8
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
14
104
1.36
0.43
1.5
1.3
ug/g
340.6
321.0
—
9
62
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
56
1.44
0.42
1.4
1.4
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
33
1.52
0.41
1.2
1.2
—
72.2
—
0
5
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
24.8
—
0
15
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
15
0.00
0.41
0.0
1.6
—
149.7
—
0
15
(40768800) Prostate Pathology biopsy report
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
8
61
1.32
0.39
2.1
2.0
g/l
131.8
131.1
—
8
44
(3037121) Protein [Mass/volume] in Urine
16
124
1.30
0.39
3.2
3.4
g/l
0.1
0.3
—
8
50
(3011648) Oxygen content in Venous blood
0
19
0.00
0.39
0.0
3.8
—
12.0
—
0
19
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
36
1.39
0.38
1.2
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
36
417
0.85
0.37
3.5
3.9
%
28.2
32.9
1.44
24
286
(3016018) Differential panel - Cerebral spinal fluid
5
37
1.35
0.37
1.0
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
98
903
1.11
0.37
1.9
1.7
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
11
81
1.37
0.36
1.9
2.9
kpa
7.3
8.5
1.15
11
76
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
14
108
1.31
0.35
2.1
2.8
mg/l
9.5
10.0
0.21
14
100
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
122
0.73
0.35
1.9
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
82
1.35
0.34
2.5
1.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
32
275
1.18
0.33
6.4
3.5
mmol/l
2.0
1.9
0.03
25
220
(3012544) pH of Venous blood
33
286
1.16
0.32
5.5
3.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
20
165
1.22
0.31
2.4
2.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
99
0.70
0.31
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
99
0.70
0.31
1.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
28
240
1.18
0.31
1.4
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
10
75
1.34
0.30
3.0
2.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
47
421
1.13
0.30
1.8
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
107
0.74
0.29
1.0
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
401
3945
1.09
0.29
18.3
11.8
%
40.2
39.9
0.30
316
3125
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
63
1.27
0.28
1.3
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
64
1.25
0.27
1.3
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
23
197
1.18
0.26
1.5
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
76
1.19
0.24
1.0
1.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
16
133
1.21
0.24
4.1
3.0
%
51.5
50.2
0.06
16
133
(3017143) Hepatitis C virus Ab [Presence] in Serum
60
553
1.10
0.24
1.8
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
37
333
1.12
0.23
1.2
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
18
153
1.18
0.22
3.0
2.0
nmol/l
11.4
11.7
0.07
18
140
(3008898) HLA-B27 [Presence]
26
229
1.14
0.22
1.2
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
68
728
0.92
0.22
2.0
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
42
1.19
0.21
1.0
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
42
1.19
0.21
1.0
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
42
1.19
0.21
1.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
0
12
0.00
0.21
0.0
1.3
—
92.0
—
0
7
(3051593) INR in Capillary blood by Coagulation assay
0
12
0.00
0.21
0.0
10.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
43
1.16
0.21
1.2
1.4
—
—
—
0
0
(4034850)
14
117
1.20
0.20
7.9
6.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
10
80
1.26
0.20
1.8
1.2
—
—
—
0
0
(3000492) Spirometry study
43
394
1.10
0.20
1.5
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
11
90
1.23
0.19
1.1
1.1
u/ml
1.0
2.0
—
5
49
(4306422)
7
59
1.19
0.18
1.1
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
18
157
1.15
0.17
1.8
1.6
—
—
—
0
0
(4094501)
10
82
1.22
0.17
1.0
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
35
321
1.10
0.17
2.4
4.1
ug/l
3.6
22.1
0.74
25
254
(1761868) Lipid panel - Serum or Plasma
169
1641
1.05
0.16
2.5
2.5
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
16
140
1.15
0.15
2.4
2.4
%
1.6
1.2
1.14
16
140
(40768793) Breast Pathology biopsy report
11
129
0.85
0.15
1.5
1.3
—
—
—
0
0
(1002224) Polysomnography panel
24
218
1.11
0.14
1.1
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
96
0.83
0.14
1.3
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
190
0.89
0.13
1.4
1.9
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
24
220
1.10
0.12
1.3
1.3
miu/ml
123.6
258.5
1.86
11
115
(44816559) Phosphatidylethanol [Mass/volume] in Blood
11
96
1.15
0.10
1.5
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
45
1.11
0.10
1.6
2.4
%
65.2
64.9
—
5
45
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
46
1.09
0.09
1.2
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
47
1.06
0.09
1.2
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
28
262
1.07
0.09
1.1
1.0
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
48
1.04
0.09
1.2
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
56
1.07
0.08
1.7
2.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
76
736
1.04
0.08
2.1
1.6
pmol/l
495.2
19401074.1
0.78
65
634
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
57
1.05
0.08
1.2
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
26
277
0.94
0.08
1.7
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
48
460
1.05
0.08
1.3
1.6
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
73
0.82
0.07
1.5
1.8
%
13.3
13.3
—
6
73
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
74
0.81
0.07
1.7
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
16
147
1.09
0.07
2.2
3.5
—
—
—
0
0
(4035726)
32
304
1.06
0.07
1.4
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
80
0.87
0.07
3.1
2.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
119
1.09
0.06
1.4
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
28
269
1.04
0.04
3.6
3.5
%
25.0
21.8
0.48
13
104
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
104
1053
0.98
0.03
1.6
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
24
249
0.96
0.02
1.7
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
14
132
1.06
0.02
5.8
9.1
mmol/l
23.2
24.5
1.50
14
125
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
132
1.06
0.02
1.2
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
35
343
1.02
0.01
1.7
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
18
185
0.97
0.00
1.8
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
18
185
0.97
0.00
2.1
1.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
22
225
0.98
0.00
1.5
1.8
mg/l
4.1
2.6
0.39
17
159
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
23
227
1.01
0.00
1.7
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
23
227
1.01
0.00
1.7
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
20
198
1.01
0.00
2.9
2.4
ug/l
0.5
0.7
1.58
13
104
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
23
228
1.01
0.00
1.7
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
23
228
1.01
0.00
1.7
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
181
0.99
0.00
1.8
1.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(4133840)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
5
0.00
0.00
0.0
1.6
—
6.2
—
0
5
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
5
53
0.94
0.00
1.2
1.5
—
12.9
—
0
5
(3008037) Lactate [Moles/volume] in Venous blood
7
70
1.00
0.00
3.0
2.5
mmol/l
1.8
1.4
—
7
70
(3001556) Androgen free Index in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
50
1.00
0.00
1.0
1.7
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
8
0.00
0.00
0.0
1.1
—
1.2
—
0
8
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
6
63
0.95
0.00
1.2
1.1
%
128.8
120.1
—
6
56
(3006576) Bicarbonate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
5.8
—
27.3
—
0
5
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
76.8
—
0
5
(3017509) Phencyclidine [Presence] in Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
88
0.91
0.00
3.1
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
60
1.00
0.00
1.2
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
18
180
1.00
0.00
1.8
1.4
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
7.5
—
0
8
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_VONVILLEBRAND and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_VONVILLEBRAND | 1.504 [1.17, 1.94] | 0.002 |
| Birth year | 0.996 [0.99, 1.0] | 0.303 |
During the follow-up period (1.1.1998 — 31.12.2019), 103 out of 1902 females with D3_VONVILLEBRAND died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_VONVILLEBRAND | 1.609 [1.22, 2.12] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.013 |
During the follow-up period (1.1.1998 — 31.12.2019), 80 out of 821 males with D3_VONVILLEBRAND died.
Mortality risk
Mortality risk for people of age
years, who have D3_VONVILLEBRAND.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.137% | 0.35% |
| 5 | 0.906% | 2.071% |
| 10 | 2.221% | 5.037% |
| 15 | 4.34% | 9.326% |
| 20 | 7.565% | 15.692% |
Relationships between endpoints
↥Index endpoint: D3_VONVILLEBRAND – Von Willebrand disease
GWS hits: 10
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data